OMED Stock Overview
Manufactures and sells medical devices and supplies under the OneMed brand in Indonesia, Asia, the United States of America, South America, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
OMED passed our risk checks.
PT Jayamas Medica Industri Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp178.00 |
| 52 Week High | Rp228.00 |
| 52 Week Low | Rp170.00 |
| Beta | -0.092 |
| 11 Month Change | -0.56% |
| 3 Month Change | -5.32% |
| 1 Year Change | -12.75% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| OMED | ID Medical Equipment | ID Market | |
|---|---|---|---|
| 7D | 1.7% | -1.0% | -2.2% |
| 1Y | -12.7% | 1.0% | 9.3% |
Return vs Industry: OMED underperformed the ID Medical Equipment industry which returned 1% over the past year.
Return vs Market: OMED underperformed the ID Market which returned 9.3% over the past year.
Price Volatility
| OMED volatility | |
|---|---|
| OMED Average Weekly Movement | 2.2% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: OMED has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: OMED's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,203 | Herlien Ariani | www.jmi.co.id |
PT Jayamas Medica Industri Tbk manufactures and sells medical devices and supplies under the OneMed brand in Indonesia, Asia, the United States of America, South America, and Africa. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising syringes, gauze, plaster bandage, masks, medical gloves, urine bag, foley cathether, alcoholic tissue, etc.; antiseptic and disinfectant liquids, povidone iodine, medical alcohol, Hdsol or blood cleansing liquid, etc.; and diagnostics and equipment, such as patient monitor, vital signs monitor, ECG reader, syringe pump, infusion pump, tensimeter, oxymeter, fingertip pulse etc. The company also provides walking aids and rehabilitation care products, including wheelchairs, crutches, walkers, arm slings etc.; biotechnology and laboratory products, such as pregnancy test, PCR test, blood collection tube, PCT tube, chemical reagents, etc; and hospital furniture products comprising patient bed, bed side cabinet, pediatric patient bed, and operation lamp, as well as other consumer medical products.
PT Jayamas Medica Industri Tbk Fundamentals Summary
| OMED fundamental statistics | |
|---|---|
| Market cap | Rp4.82t |
| Earnings (TTM) | Rp287.90b |
| Revenue (TTM) | Rp1.84t |
16.7x
P/E Ratio2.6x
P/S RatioIs OMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMED income statement (TTM) | |
|---|---|
| Revenue | Rp1.84t |
| Cost of Revenue | Rp1.24t |
| Gross Profit | Rp599.80b |
| Other Expenses | Rp311.89b |
| Earnings | Rp287.90b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.64 |
| Gross Margin | 32.69% |
| Net Profit Margin | 15.69% |
| Debt/Equity Ratio | 6.7% |
How did OMED perform over the long term?
See historical performance and comparison